Business
Novo Nordisk Expands Obesity Strategy Globally
Following a successful U.S. launch of its weight loss pill, Novo Nordisk is now targeting other global markets with the same product strategy.
Coverage timeline — 1 article
CNBC
The weight loss pill had a strong U.S. launch this year, and Novo believes that will be replicated in other markets around the world.
2026-05-18 05:00 UTC